The stock chart, a fascinating visual representation of hope and regret, clearly demonstrates how quickly capital can evaporate. But beneath the surface, Chewy is… progressing. Revenue increased year-over-year in Q3 2025, and profits grew at an even more encouraging rate. This is good, obviously. But before rushing to embrace the canine-and-feline-themed financial future, a few considerations are in order.
We’ve already peeled back the layers on this operation—how they clawed their way back from the abyss, the financial autopsy. This, the final dispatch from the Voyager Portfolio, is about looking into the abyss, and seeing if it’s worth investing before it stares back with a stock certificate in its teeth. Because let’s be clear: this isn’t about technology anymore, it’s about survival.
Now, a partnership with Nvidia has caused a ripple – a very small ripple, admittedly – in the financial ponds. Wall Street, ever susceptible to shiny objects, is taking notice. The claim is this could be Nokia’s moment. A ‘recovery.’ A ‘long-term winner.’ (These phrases, incidentally, should always be viewed with the same level of skepticism one reserves for fortune cookies and unsolicited email.) The idea is that Nokia is transforming itself – yet again – into an ‘AI company.’ (A term that currently means very little, but sounds impressive during earnings calls.)
This addition, representing nearly 2% of Palisades’ portfolio—a portfolio itself totaling $264.72 million—is not merely a numerical transaction. It is a whisper of conviction, a subtle shift in the wind. The firm now holds a constellation of equities: STRL at $29.86 million, SPXC at $23.04 million, WGS at $11.34 million, KRYS at $10.54 million, and MMYT at $9.80 million, each a star in its own right. But it is Travere that now draws the eye, a fledgling bloom amidst established trees.
CHAT, you see, is a creature of recent vintage, sprung forth from the ether following the sudden pronouncements of a digital oracle named ChatGPT. It proclaims itself a champion of “generative” intelligence – as if intelligence could be generated, like so many pamphlets in a provincial town. VGT, on the other hand, is a veteran of countless market skirmishes, a broad and sprawling empire of technology, its holdings numbering in the hundreds. It is the sort of fund one might expect to encounter presiding over a dusty archive, meticulously cataloging every conceivable innovation, no matter how trivial.
Three years have passed since the advent of generative artificial intelligence, birthed from the laboratories of OpenAI. A veritable frenzy of valuation followed, inflating the market capitalization of countless companies, rendering the search for genuine value increasingly difficult. Micron Technology, too, has felt the upward draft, yet its valuation, considered against the burgeoning demand for its wares, remains… restrained. A peculiar circumstance, worthy of closer inspection.
Higher yields, of course, often whisper tales of hidden perils. But with Oneok, the foundations appear…solid. Not merely stable, mind you, but imbued with a certain…obstinacy. It’s a rock, if you will, refusing to be moved by the whims of fortune. This allows them, quite brazenly, to offer investors yet another raise. One imagines the accountants are having palpitations, but the directors seem…amused.
The SPDW, she’s a bit like a sturdy, no-nonsense riverboat, stickin’ to the well-charted waters of established nations. The ACWX, now, she’s a bit more adventurous, willin’ to venture into the wilder reaches of developin’ lands. Both are large ETFs, mind, but one’s a bit more selective in its company than the other. It’s a matter of what kind of risk a fella’s willing to court, and how much he values a smooth sail versus a bit of a thrill.
The company’s valuation last year was, shall we say, ambitious. It was like they were pricing in the singularity before they’d actually built a decent chatbot. Now, a dip can create an opportunity, but it also begs the question: is this a correction, or are we witnessing a slow-motion tech crash?
I took a look. Digging through the numbers, the fine print, the stuff most investors skip. Trying to figure out which one, if either, is worth the bother. It’s a close-run thing, this one. Like betting on which alley cat will cross the street first.